53-57-6 (NADPH,NADPH)

快速询单

结构式：

NADPHMOL文件

CAS号：

53-57-6

中文名称：

NADPH

英文名称：

NADPH

分子式：

C₂₁H₃₀N₇O₁₇P₃

分子量：

745.420887470245

NADPH(53-57-6)名称与标识符

名称

中文别名：

还原型辅酶II(NADPH)四钠盐;

英文别名：

[[(2S,3S,4S,5S)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxy-te trahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] [(2S,3R,4S,5S)-5-( 3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]m et;Adenosine5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'®β-NADPH-d4;5'-ester with 1,4-dihydro-1-b-D-ribofuranosyl-3-pyri;5'-ester with 1,4-dihydro-1-b-D-ribofuranosyl-3-pyridinecarboxamide;Di-(tert-butyl) imidodicarbonate;Di-t-butyl iminodicarboxylate;di-tert-butyl imidodicarbonate;di-tert-butyl iminodicarbonate;Di-tert-butyl Iminodicarboxylate;Di-tert-butyl-iminodicarboxylate;Iminodicarboxylic Acid Di-tert-butyl Ester;N-Boc-tert-butylcarbamate;tert-Butyl iminodicarboxylate; β-TPNH; β-Nicotinamide-adenine-dinucleotide-phosphoric acid; β-NADPH; Triphosphopyridine nucleotide, reduced; TPNH; Reduced triphosphopyridine nucleotide; Reduced nicotinamide adenine dinucleotide phosphate; Reduced 2 codehydrogenase II; Nicotinamide-adenine dinucleotide phosphate, reduced; NADPH ; Dihydrocodehydrogenase II; Cozymase II, reduced; Coenzyme II, reduced; Codehydrogenase II, reduced; Codehydrase II, reduced; 51: PN: WO2004076659 FIGURE: 7 claimed sequence;Adenosine, 2'-(dihydrogen phosphate) 5'-(trihydrogen pyrophosphate), 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (8CI);Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide;53-57-6;b-Nicotinamide-adenine-dinucleotide-phosphorate;Dihydrocodehydrogenase II;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;C21-H30-N7-O17-P3.4Na;NADP REDUCED FORM [MI];ACFIXJIJDZMPPO-NNYOXOHSSA-N;DTXSID001018921;beta-Nicotinamide-adenine-dinucleotide-phosphoric acid;C00005;C21H30N7O17P3;DB02338;Nicotinamide-adenine-dinucleotide-phosphorate;CHEBI:16474;EINECS 200-177-6;ADENOSINE 5'-(TRIHYDROGEN DIPHOSPHATE), 2'-(DIHYDROGEN PHOSPHATE), P'->5'-ESTER WITH 1,4-DIHYDRO-1-.BETA.-D-RIBOFURANOSYL-3-PYRIDINECARBOXAMIDE;beta-Nicotinamide-adenine-dinucleotide-phosphorate;NADP REDUCED FOM;C21-H30-N7-O17-P3;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;reduced Cozymase II;beta-NADPH Tetrasodium;CHEMBL407009;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), 5'.fwdarw.5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;Reduced Nicotinamide Adenine Dinucleotide Phosphate;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'?5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide;reduced nicotinamide-adenine dinucleotide phosphate;REDUCED CODEHYDROGENASE II;COENZYME II, REDUCED;dihydrotriphosphopyridine nucleotide reduced;NADPH;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogenphosphate), P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;Reduced triphosphopyridine nucleotide;reducednicotinamide-adenine dinucleotide phosphate;NADPH2;reduced Coenzyme II;.BETA.-NADPH;2646-71-1;Nicotinamide-adenine-dinucleotide-phosphoric acid;2'-(dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) Adenosine 5'-ester with 1,4-dihydro-1-b-D-ribofuranosylnicotinamide;dihydronicotinamide adenine dinucleotide-P;Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) P'-5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosyl-3-pyridinecarboxamide;TPNH;Nicotinamide-adenine dinucleotide phosphate, reduced;NADP-reduced;b-NADPH;Triphosphopyridine nucleotide reduced;.BETA.-NICOTINAMIDE-ADENINE-DINUCLEOTIDE-PHOSPHORIC ACID;Adenosine 5'-(trihydrogen diphosphate) 2'-(dihydrogen phosphate) P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate;2'-O-phosphonoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate};beta-NADPH;dihydronicotinamide adenine dinucleotide phosphate;bmse000055;nadph hydride;b-Nicotinamide-adenine-dinucleotide-phosphoric acid;2'-(dihydrogen phosphate) 5'-(trihydrogen pyrophosphate) Adenosine 5'-ester with 1,4-dihydro-1-beta-delta-ribofuranosylnicotinamide;381Q4X082D;Nicotinamide adenine dinucleotide phosphate - reduced;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;reduced Codehydrase II;UNII-381Q4X082D;Q26841327;[(2R,3R,4R,5R)-2-(6-Aminopurin-9-yl)-5-[[[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxymethyl]-4-hydroxy-oxolan-3-yl]oxyphosphonic acid;SCHEMBL2041;C21H30N7O17P3.4Na;Dihydronicotinamide-adenine dinucleotide phosphate;Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'.fwdarw.5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide;Adenosine, 2'-(dihydrogen phosphate) 5'-(trihydrogen pyrophosphate), 5'→5'-ester with 1,4-dihydro-1-β-D-ribofuranosylnicotinamide (8CI);51: PN: WO2004076659 FIGURE: 7 claimed sequence;Codehydrase II, reduced;Codehydrogenase II, reduced;Cozymase II, reduced;Triphosphopyridine nucleotide, reduced;β-NADPH;β-Nicotinamide-adenine-dinucleotide-phosphoric acid;β-TPNH;NS00015230;NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE;NADPH tetraanion;Dihydronicotinamide-adenine dinucleotide phosphoric acid;(((2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-((((((((2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)methyl)-4-hydroxyoxolan-3-yl)oxy)phosphonic acid;NADPH dihydro-nicotinamide-adenine-dinucleotide phosphoric acid;HY-113324;[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate;DA-55982;NADP-red;[(2S,3S,4S,5S)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2S,3R,4S,5S)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate;Nucleotide, Triphosphopyridine;25 MG -NICOTINAMIDE ADENINE DINUCLEOTIDEPHOSPHATE REDUCED.NA4-SALT AN.GR.;Reduced nicotinamide adenine dinucleotide phosphoric acid;Adenosine 5'(trihydrogen diphosphate), 2'(dihydrogen phosphate), P'.fwdarw.5'ester with 1,4dihydro1betaDribofuranosyl3pyridinecarboxamide;(((2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl)methoxy-hydroxyphosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoyl-1,4-dihydropyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl phosphate;beta-TPNH;Reduced nicotinamide-adenine dinucleotide phosphoric acid;reduced NADP;Dihydronicotinamideadenine dinucleotide phosphate;{[(2S,3S,4S,5S)-2-(6-amino-9H-purin-9-yl)-5-[({[({[(2S,3R,4S,5S)-5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid;(((2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl)methoxy-hydroxyphosphoryl) ((2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methyl hydrogen phosphate;DTXCID201476935;dihydronicotinamide adenine dinucleotide phosphate reduced;Adenosine 5'(trihydrogen diphosphate), 2'(dihydrogen phosphate), P'>5'ester with 1,4dihydro1betaDribofuranosyl3pyridinecarboxamide;dihydrotriphosphopyridine nucleotide;NADP REDUCED FORM;2'-O-phosphonoadenosine 5'-(3-(1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl) dihydrogen diphosphate);Phosphate, Nicotinamide-Adenine Dinucleotide;((2S,3S,4S,5S)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl)methyl (((2S,3R,4S,5S)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) hydrogen phosphate;CS-0059609;Dinucleotide Phosphate, Nicotinamide-Adenine;Nadph dihydro-nicotinamide-adenine-dinucleotidephosphoric acid;reduced dihydrotriphosphopyridine nucleotide;

标识符

InChIKey：

ACFIXJIJDZMPPO-NNYOXOHSSA-N

Inchi：

1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1

SMILES：

P(=O)(O)(O)O[C@H]1[C@H](N2C=NC3C(N)=NC=NC2=3)O[C@H](COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@H](N3C=CCC(C(N)=O)=C3)O2)O)O)[C@H]1O

NADPH(53-57-6)物化性质

实验特性

LogP : -0.90060
PSA : 394.57000
折射率 : 1.849
沸点 : 1175.1°Cat760mmHg
闪点 : 664.5°C
密度 : 2.28

计算特性

精确分子量 : 745.091102
氢键供体数量 : 9
氢键受体数量 : 18
可旋转化学键数量 : 13
同位素质量 : 745.091102
重原子数量 : 48
复杂度 : 1410
同位素原子数量 : 0
确定原子立构中心数量 : 8
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : _6.8
拓扑分子极性表面积 : 364

NADPH(53-57-6)推荐厂家更多厂家(9)

公司名称	手机号/电话	联系人	QQ	询单
上海楷森生物科技有限公司	17558870519 175-58870519	赵经理	3003926540	询单
上海源叶生物科技有限公司	15026964105 15026964105	汤思磊	2881489226	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
湖北健楚生物医药有限公司	13477033894 027-65528557	王经理	3821225285	询单
金锦乐（湖南）化学有限公司		金锦乐	1226360695	询单
上海依赫生物科技有限公司	17721395025 021-68882955	张经理	2423903095	询单
杭州六可生物科技有限公司	15658003402 0086-571-86912261	Susan	3671025517	询单
上海麦克林生化科技股份有限公司	15221275939 021-50706066	沈经理	269348414	询单
苏州探科生物科技有限公司	18962323641	王工	2813290504	询单

NADPH(53-57-6)合成路线

合成路线：1 步

反应条件：

1.1R:i-PrNH2, S:H2O, 8 h, 25°C, pH 8

参考文献：

Transforming inert cycloalkanes into α,ω-diamines by designed enzymic cascade catalysis

By Zhang, Zhongwei et al, Angewandte Chemie, 2023, 62(16), e202215935

合成路线：1 步

53-59-8

_76%

53-57-6

反应条件：

1.1R:C:15086-94-9 (reaction products with aminomethylpolystyr), C:2920852-50-0, S:H2O

参考文献：

Polystyrene-based eosin-Y as a photocatalyst for solar light-mediated NADH/NADPH regeneration and organic transformations

By Singh, Pooja et al, Reaction Chemistry & Engineering, 2023, 8(5), 1072-1082

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1C:CdS

参考文献：

Protein-Mediated Biosynthesis of Semiconductor Nanocrystals for Photocatalytic NAD(P)H Regeneration and Chiral Amine Production

By Bachar, Oren et al, Angewandte Chemie, 2022, 61(23), e202202457

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:HCl, S:H2O, 10 min

参考文献：

An Implantable Ionic Wireless Power Transfer System Facilitating Electrosynthesis

By Kim, Chong-Chan et al, ACS Nano, 2020, 14(9), 11743-11752

合成路线：1 步

反应条件：

1.1R:HCO2- •Na+, R:(NH4)2SO4, C:1449222-31-4, S:H2O, 1.5 h, < 40°C, pH 7.4; 1 h, < 40°C, pH 7.4
1.2R:PhNCS, R:Et3N, S:MeCN, 1 h, rt

参考文献：

The visible-light-driven transfer hydrogenation of nicotinamide cofactors with a robust ruthenium complex photocatalyst

By Dong, Wenjin et al, Green Chemistry, 2020, 22(7), 2279-2287

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1

参考文献：

Development of an enzymatic process for the synthesis of (S)-2-chloro-1-(2,4-dichlorophenyl) ethanol

By Wei, Teng-Yun et al, Organic Process Research & Development, 2019, 23(9), 1822-1828

合成路线：1 步

反应条件：

1.1R:MgCl2, R:Na2HPO4, R:NH4Cl, R:NaCl, R:MgSO4, R:KH2PO4, S:H2O, 37°C

参考文献：

Co-production of hydrogen and ethanol by pfkA-deficient Escherichia coli with activated pentose-phosphate pathway: reduction of pyruvate accumulation

By Sekar, Balaji Sundara et al, Biotechnology for Biofuels, 2016, 9, 95/1-95/11

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:Me2CHOH, S:H2O, 30 min, 40°C, pH 9.0

参考文献：

Contribution to catalysis of ornithine binding residues in ornithine N5-monooxygenase

By Robinson, Reeder et al, Archives of Biochemistry and Biophysics, 2015, 585, 25-31

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1C:9029-33-8, S:H2O, 6°C, pH 8.0

参考文献：

Structural backgrounds for the formation of a catalytically competent complex with NADP(H) during hydride transfer in ferredoxin-NADP+ reductases

By Sanchez-Azqueta, Ana et al, Biochimica et Biophysica Acta, 2012, 1817(7), 1063-1071

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:N(CH2CH2OH)3, C:1366596-70-4 (reaction product with carboxy-functionaliz), C:121596-51-8, S:H2O, S:DMF, 150 min, rt, pH 7

参考文献：

A Photocatalyst/Enzyme Couple That Uses Solar Energy in the Asymmetric Reduction of Acetophenones

By Choudhury, Sumit et al, Angewandte Chemie, 2012, 51(46), 11624-11628

合成路线：1 步

反应条件：

1.1C:9028-12-0, C:9028-53-9, S:H2O, S:DMSO, 4 h, 30°C, pH 7.5

参考文献：

Application of biocatalysis towards asymmetric reduction and hydrolytic desymmetrisation in the synthesis of a β-3 receptor agonist

By Badland, Matthew et al, Green Chemistry, 2011, 13(10), 2888-2894

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:Cleland's reagent, R:N(CH2CH2OH)3, R:NaOD, S:H2O, 4 h, rt, pH 8.9

参考文献：

Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes

By Patton, Gregory C. et al, Nature Chemical Biology, 2011, 7(12), 950-958

合成路线：1 步

反应条件：

1.1R:Cleland's reagent, R:MgCl2, R:R:R:R:R:R:H2O, R:KOH, R:NH4Cl, C:56-65-5, C:Coenzyme II, C:9001-51-8, C:9001-40-5, C:9073-95-4, C:9023-83-0, C:9015-83-2, C:9026-23-7, C:9012-49-1, C:9024-93-5, C:9029-03-2, C:9030-25-5, C:9024-62-8, C:37278-21-0, C:9013-02-9, C:9029-12-3, C:9001-15-4, C:1927-31-7, S:H2O

参考文献：

Enzymatic De Novo Pyrimidine Nucleotide Synthesis

By Schultheisz, Heather L. et al, Journal of the American Chemical Society, 2011, 133(2), 297-304

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1S:872672-50-9, S:H2O, pH 7

参考文献：

Ionic Liquids as Performance Additives for Electroenzymatic Syntheses

By Kohlmann, Christina et al, Chemistry - A European Journal, 2009, 11692-11700, S11692/1-S11692/11

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1C:121596-52-9, S:H2O, pH 7

参考文献：

Synthesis, characterization and application of new rhodium complexes for indirect electrochemical cofactor regeneration

By Hildebrand, Falk et al, Advanced Synthesis & Catalysis, 2008, 350(6), 909-918

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:D-Glucose, C:9028-53-9

参考文献：

α-Secondary Isotope Effects as Probes of "Tunneling-Ready" Configurations in Enzymatic H-Tunneling: Insight from Environmentally Coupled Tunneling Models

By Pudney, Christopher R. et al, Journal of the American Chemical Society, 2006, 128(43), 14053-14058

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:Zn (myoglobin complex), R:N(CH2CH2OH)3, 3.5 h, rt, pH 9; 7 d, rt, pH 9

参考文献：

Phototriggered chemical reduction of NADP+ by Zn-reconstituted myoglobin and triethanolamine as a sacrifical donor

By Nishiyama, Katsuhiko et al, Chemistry Letters, 2005, 34(7), 1032-1033

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:Tris buffer, R:H2, C:9027-05-8, S:774-48-1, 1 h, 40°C, 2.3 bar, pH 8

参考文献：

Reaction engineering aspects of enzymic manufacture of NADPH in an enzyme membrane reactor

By Mertens, Rita et al, Chemie Ingenieur Technik, 2005, 77(5), 609-616

合成路线：1 步

53-59-8

_99%

53-57-6

反应条件：

1.1C:160261-98-3, S:H2O, 20-25°C, pH 8

参考文献：

Indirect electrochemical reduction of nicotinamide coenzymes

By Vuorilehto, K. et al, Bioelectrochemistry, 2004, 65(1), 1-7

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:H2, C:9027-05-8, S:H2O, 2 h, 40°C, 5 bar, pH 8

参考文献：

Membrane aerated hydrogenation: Enzymatic and chemical homogeneous catalysis

By Greiner, Lasse et al, Advanced Synthesis & Catalysis, 2003, 345(6+7), 679-683

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:H2, C:9027-05-8 (immobilized), 80°C
1.2S:H2O, 40°C, pH 8.5

参考文献：

Utilization of adsorption effects for the continuous reduction of NADP+ with molecular hydrogen by Pyrococcus furiosus hydrogenase

By Greiner, L. et al, Green Chemistry, 2003, 5(6), 697-700

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1R:H2, C:142903-68-2, S:H2O, 3 h, 40°C, 70 psi, pH 8.3

参考文献：

Transition-Metal-Catalyzed Regeneration of Nicotinamide Coenzymes with Hydrogen

By Wagenknecht, Paul S. et al, Organometallics, 2003, 22(6), 1180-1182

合成路线：1 步

53-59-8

53-57-6

反应条件：

1.1

参考文献：

NADPH manufacture using permeabilized microorganisms

By Silhankova, Ludmila and Hajek, Petr, Czech., From Czech., 266763, 12 Jan 1990, 266763, 12 Jan 1990

NADPH(53-57-6)相关文献

1. Slow magnetic relaxation in lanthanide ladder type coordination polymers
Penka I. Girginova,Laura C. J. Pereira,Joana T. Coutinho,Isabel C. Santos,Manuel Almeida Dalton Trans. 2014 43 1897
2. Structure of hopeaphenol: X-ray analysis of the benzene solvate of dibromodeca-O-methylhopeaphenol
P. Coggon,A. T. McPhail,S. C. Wallwork J. Chem. Soc. B 1970 884
3. Structure and stability of carboxylate complexes. Part I. The crystal and molecular structures of copper(II) glycollate, DL-lactate, 2-hydroxy-2-methylpropionate, methoxyacetate, and phenoxyacetate
C. K. Prout,R. A. Armstrong,J. R. Carruthers,J. G. Forrest,P. Murray-Rust,F. J. C. Rossotti J. Chem. Soc. A 1968 2791
4. Imidazoles as potential anticancer agents
Imran Ali,Mohammad Nadeem Lone,Haasan Y. Aboul-Enein Med. Chem. Commun. 2017 8 1742
5. A comprehensive analysis of subclass-specific IgG glycosylation in colorectal cancer progression by nanoLC-MS/MS
Si Liu,Yang Fu,Zhiwen Huang,Yuanyuan Liu,Bi-Feng Liu,Liming Cheng,Xin Liu Analyst 2020 145 3136